Phenotyping sleep apnoea: cardiovascular aspects and chemosensitivity

J.A. Hedner (Gothenburg, Sweden)

Source: ERS Conference
Number: 90

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J.A. Hedner (Gothenburg, Sweden). Phenotyping sleep apnoea: cardiovascular aspects and chemosensitivity. ERS Conference

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Phenotyping sleep apnoea: morphology and obesity
Source: ERS Conference
Year: 2015

Phenotyping sleep apnea patients.
Source: 5th Sleep and Breathing Conference
Year: 2019

Cardiovascular and metabolic consequences of obstructive sleep apnoea
Source: Eur Respir J 2001; 18: Suppl. 33, 519s
Year: 2001

Pathophysiological consequences of obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006


Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study
Source: Eur Respir J 2013; 41: 360-367
Year: 2013



Obstructive sleep apnea and specific cardiovascular outcomes
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018

Sleep apnoea and hypoventilation syndromes - cardiometabolic consequences
Source: International Congress 2018 – PG7 Sleep-disordered breathing - diagnosis and therapy
Year: 2018


Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007


Obstructive sleep apnea and cardiovascular risk in Chinese population: a Meta-analysis
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017

Cardiovascular comorbidity by clinical phenotypes of obstructive sleep apnea and sleeping hours
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020


Phenotyping comorbidity in obstructive sleep apnea syndrome
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults II: questionnaires, epidemiology and sleep studies
Year: 2015

Clinical assessment of obstructive sleep apnoea
Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts
Year: 2006



Physical activity: the key to cardiometabolic risk reduction in obstructive sleep apnoea
Source: Eur Respir J, 52 (4) 1801775; 10.1183/13993003.01775-2018
Year: 2018



Impact of cardiorespiratory sleep staging for home sleep apnea testing
Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea
Year: 2020


Relationship between sleep apnoea and cancer
Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021
Year: 2021


Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA)
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015